Accès gratuit
Med Sci (Paris)
Volume 21, Numéro 12, Décembre 2005
Page(s) 1070 - 1075
Section M/S revues
Publié en ligne 15 décembre 2005
  1. Greaves DR, Gordon S. Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol 2002; 76 : 6–15.
  2. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296 : 298–300.
  3. Denkers EY. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol 2003; 39 : 193–203.
  4. Pawelek JM. Tumour cell hybridization and metastasis revisited. Melanoma Res 2000; 10 : 507–14.
  5. Vignery A, Niven-Fairchild T, Ingbar DH, Caplan M. Polarized distribution of Na+,K+-ATPase in giant cells elicited in vivo and in vitro. J Histochem Cytochem 1989; 37 : 1265–71.
  6. Vignery A. Macrophage multinucleation is accompanied by the expression of new soluble and membrane antigens in mice. Am J Pathol 1989; 135 : 565–70.
  7. Vignery A Niven-Fairchild T, Shepard MH. Recombinant murine interferon gamma inhibits the fusion of mouse alveolar macrophages in vitro but stimulates the formation of osteoclast-like cells on implanted syngeneic bone particles in vivo. J Bone Miner Res 1990; 5 : 637–44.
  8. Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol 2000; 81 : 291–304
  9. Saginario C, Qian HY, Vignery A. Identification of an inducible surface molecule specific to fusing macrophages. Proc Natl Acad Sci USA 1995; 92 : 12210–4.
  10. Saginario C, Sterling H, Beckers C, et al. MFR, a putative receptor mediating the fusion of macrophages. Mol Cell Biol 1998; 18 : 6213–23.
  11. Sterling H, Saginario C, Vignery A. CD44 occupancy prevents the fusion of macrophages. J Cell Biol 1998; 143 : 837–47.
  12. Han X, Sterling H, Chen Y, et al. CD47, a ligand for MFR, participates in macrophage multinucleation. J Biol Chem 2000; 275 : 37984–92.
  13. Kharitonenkov A, Chen Z, Sures I, et al. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 1997; 386 : 181–6.
  14. Fujioka Y, Matozaki T, Noguchi T, et al. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 1996; 16 : 6887–99.
  15. Sano S, Ohnishi H, Omori A, et al. BIT, an immune antigen receptor-like molecule in the brain. FEBS Lett 1997; 411 : 327–34.
  16. Comu S, Weng W, Olinsky S, et al. The urine P84 neural adhesion molecule is SHPS-1, a member of the phosphatase-binding protein family. J Neurosci 1997; 17 : 8702–10.
  17. Brooke GP, Parsons KR, Howard CJ. Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. Eur J Immunol 1998; 28 : 1–11.
  18. Dalgleish AG, Beverley PC, Clapham PR, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312 : 763–7.
  19. Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984; 312 : 767–8.
  20. Oshima K, Ruhul Amin AR, Suzuki A, et al. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS Lett 2002; 519 : 1–7.
  21. Cant CA, Ullrich A. Signal regulation by family conspiracy. Cell Mol Life Sci 2001; 58 : 117–24.
  22. Kajita M, Itoh Y, Chiba T, et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153 : 893–904.
  23. Yagi M, Miyamoto T, Sawatani Y, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005; 202 : 345–51.
  24. Vignery A. Macrophage fusion : the making of osteoclasts and giant cells. J Exp Med 2005; 202 : 337–40.
  25. Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from Toll-like receptors. Science 2004; 304 : 1014–8.
  26. Williamson P, Schlegel RA. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim Biophys Acta 2002; 1585 : 53–63.
  27. Van den Berg TK, Yoder JA, Litman GW. On the origins of adaptive immunity: innate immune receptors join the tale. Trends Immunol 2004; 25 : 11–6.
  28. Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells. Science 2000; 288 : 2051–4.
  29. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422 : 901–4.
  30. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422 : 897–901.
  31. Vassillopoulos G, Russell DW. Cell fusion: an alternative to stem cell plasticity and its therapeutic implication. Curr Opin Genet Dev 2003; 13 : 480–5.
  32. Medvinsky A, Smith A. Fusion brings down barriers. Nature 2003; 422 : 823–5.
  33. Willenbring H, Bailey AS, Foster M, et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 2004; 10 : 744–8.
  34. Camargo FD, Chambers SM, Goodell MA. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 2004; 113 : 1266–71.
  35. Camargo FD, Chambers SM, Goodell MA. Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif 2004; 37 : 55–65.
  36. Chakraborty AK, De Freitas Sousa J, Espreafico EM, Pawelek JM. Human monocyte x mouse melanoma fusion hybrids express human gene. Gene 2001; 275 : 103–6.
  37. Chakraborty AK, Kolesnikova N, Sousa J, et al. Expression of c-met proto-oncogene in metastatic macrophages X melanoma fusion hybrids: implication of its possible role in MSH-induced motility. Oncol Res 2003; 14 : 163–74.
  38. Duelli D, Lazebnik Y. Cell fusion: a hidden enemy ? Cancer Cell 2003; 3 : 445–8.
  39. Ohnishi H, Kobayashi H, Okazawa H, et al. Ectodomain shedding of SHPS-1 and its role in regulation of cell migration. J Biol Chem 2004; 279 : 27878–87.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.